# CT Air-trapping for the Early Identification of Benralizumab Responders Among Eosinophilic Asthma Patients

> **NCT03976310** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 59 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** 48 weeks of Benralizumab
- **OTHER:** Computed tomography

## Key facts

- **NCT ID:** NCT03976310
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-20
- **Primary completion:** 2023-06-09
- **Final completion:** 2023-06-09
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2023-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03976310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03976310, "CT Air-trapping for the Early Identification of Benralizumab Responders Among Eosinophilic Asthma Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03976310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*